ACE2 and chronic obstructive pulmonary disease: In keeping with our findings in human COPD cells, elastase-treated mice had significantly increased (∼5-fold) lung Ace2 expression at 10 days, with further enhancement to more than 15-fold at 17 days (Fig 6, B).